Literature DB >> 27863745

A Systematic Review of Voice Therapy: What "Effectiveness" Really Implies.

Maude Desjardins1, Lucinda Halstead2, Melissa Cooke3, Heather Shaw Bonilha4.   

Abstract

INTRODUCTION: Behavioral voice therapy guided by a speech-language pathologist is recommended as the main treatment approach for many kinds of voice disorders. Encouraging evidence regard of good outcomes from voice therapy has been found in two previous reviews on broad patient populations. However, no definitive conclusion on the effectiveness of direct voice therapy can be drawn from these reviews due to limitations of the included studies. AIMS: To review recent literature on voice therapy; to provide clinicians with a list of evidence-based voice therapy techniques; to incorporate the therapy components in a physiologically based model; to assess the limitations and progress achieved in the recent research on voice therapy.
METHODS: A literature search was conducted using three electronic databases: PubMed, Scopus, and CINAHL. A similar strategy was used in all three databases to highlight the concepts of "therapy" and "voice disorders." Only randomized controlled trials were included in the review.
RESULTS: Fifteen papers met the inclusion criteria, covering five categories of voice disorders (functional, Parkinson induced, GERD induced, presbyphonia, unilateral vocal fold paresis) and seven specific behavioral voice therapy approaches. Statistically significant improvements were found postintervention on at least one outcome variable in all but one study. Clinical significance of the results was rarely discussed. Discrepancies in reported outcome measures were found across studies, making comparisons between interventions challenging.
CONCLUSION: Behavioral voice therapy generally leads to significant improvements in voice outcomes, but further research considering clinical meaningfulness of the results are needed to establish what is really meant by the term "effectiveness" when it comes to voice therapy.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Dysphonia; Review; Voice; Voice disorder; Voice therapy

Mesh:

Year:  2016        PMID: 27863745     DOI: 10.1016/j.jvoice.2016.10.002

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  6 in total

1.  Test-Retest Reliability of Relative Fundamental Frequency and Conventional Acoustic, Aerodynamic, and Perceptual Measures in Individuals With Healthy Voices.

Authors:  Yeonggwang Park; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2019-06-10       Impact factor: 2.297

2.  Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor.

Authors:  Miki Nozawa; Satoka Takahashi; Takeharu Kanazawa; Kazuya Kurakami; Tomohiro Hasegawa; Mayu Hirosaki; Manami Kamitomai; Daigo Komazawa; Ujimoto Konomi; Makoto Ito; Yusuke Watanabe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-22

3.  Parameters and Scales Used to Assess and Report Findings From Stroboscopy: A Systematic Review.

Authors:  Heather Shaw Bonilha; Maude Desjardins; Kendrea L Garand; Bonnie Martin-Harris
Journal:  J Voice       Date:  2017-11-02       Impact factor: 2.009

4.  Mapping Meta-Therapy in Voice Interventions onto the Rehabilitation Treatment Specification System.

Authors:  Leah B Helou; Jackie L Gartner-Schmidt; Edie R Hapner; Sarah L Schneider; Jarrad H Van Stan
Journal:  Semin Speech Lang       Date:  2021-02-17       Impact factor: 1.761

5.  Impaired auditory discrimination and auditory-motor integration in hyperfunctional voice disorders.

Authors:  Defne Abur; Austeja Subaciute; Mara Kapsner-Smith; Roxanne K Segina; Lauren F Tracy; J Pieter Noordzij; Cara E Stepp
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.996

6.  Effects of a conservative in-patient voice treatment on the voice-related self-concept.

Authors:  Bernhard Lehnert; Manfred Nusseck; Fei Lu; Annerose Keilmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-10       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.